Bhiman JN, Moore PL. Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concern. Immunol Rev. 2022;310(1):61-75. https://doi.org/10.1111/imr.13086
Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concern.
By Peter Matlawa|2023-03-15T15:38:16+02:00March 15, 2023|2022: April to June|Comments Off on Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concern.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Antimicrobial susceptibility and genomic profiling of Salmonella enterica from bloodstream infections at a tertiary referral hospital in Lusaka, Zambia, 2018-2019.